top of page

For more recent updates, check out:

December 2017

Julian Praceus presents the concept of an AI & Cloud-based platform for structural heart interventions in the ICI Start-up Competition in Tel-Aviv.

March 2019

LARALAB Platform is used in R&D and early trial stages of three Mitral & Tricuspid devices.

August 2018

Founders Julian Praceus, Alex Vasilev and Julian Bernard kick-off LARALAB's business with the first one-room office in Munich.

November 2020

LARALAB appoints Dr. Peter Vorländer, former Philips Innovation Lead and Managing Director Philips Medical Systems GmbH to LARALAB's Board.

October 2021

LARALAB wins Munich Marathon Team Competition.

May 2022

The LARALAB Platform receives CE marking under MDR along with its tricuspid valve workflow.

May 2022

The CE-marked LARALAB Platform is officially launched at the PCR congress in Paris.

May 2018

LARALAB's first generation of Deep Learning segmentations from Cardiac CT indicates potential performance beyond-state-of-the-art.

October 2018

LARALAB was selected for the Philips Global AI start-up program from 700 start-ups: the only one in a pre-funding stage.

June 2019

Julian Praceus presents a new decision-support concept for Mitral & Tricuspid interventions at CSI Frankfurt.

November 2019

LARALAB successfully completes proof-of-concept for automatic algorithms in collaboration with Prof. Dr. Jeffrey J. Popma and Dr. Felix Kreidel.

January 2020

LARALAB closes Series A financing round with the goal to bring the LARALAB Platform to the market.

September 2020

LARALAB grows to a competitive team of 10.

November 2021

LARALAB gets Quality Management System certified by TÜV Süd, in accordance with ISO 13485 and Medical Device Regulation (MDR) 2017/745.

August 2022

LARALAB grows to 20 team members and plays the first LARALAB open.

September 2022

LARALAB celebrates the opening of the new headquarters in Munich. 

February 2023

LARALAB launches advanced mitral valve workflow for investigational and research use by selected partners.

September 2023

LARALAB raises 5.7M € in a Series A2 round to further drive platform innovations together with partnering heart centers and device companies.

April 2024

LARALAB launches the powerful Gen2 Platform.

May 2024

LARALAB launches REC Rapid Eligibility check, capable of eliminating ineligible pathways in seconds.


Our Story

bottom of page